Business The Biologics Inflection Point: Managing The Risk From Biosimilar Competition

1. L E K . C O ML.E.K. Consulting / Executive Insights EXECUTIVE INSIGHTS INSIGHTS @ WORKTM VOLUME XVI, ISSUE 10 The Biologics Inflection Point: Managing The Risk From Biosimilar…